US equities |
MU $878.84 ▼-5.63% NVDA $214.13 ▼-1.43% TSLA $354.72 ▼-2.13% AAPL $343.46 ▲+0.43% META $709.33 ▼-3.72% MSFT $529.05 ▼-1.93% SPCX $146.03 ▼-1.74% AMD $528.75 ▼-5.95%
FinancialContent

Bionoid Pharma Inc (OP:BINP)

0.0380 UNCHANGED
Last Price Updated: 2:49 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionoid Pharma Inc

< Previous 1 2 Next >
InvestorNewsBreaks – AI Maverick Intel Inc. (OTC: BINP OTC: AIMV) Begins Trading Under New Ticker Reflecting AI-Focused Rebrand
Via Investor Brand Network
Topics Artificial Intelligence
AI Maverick Intel Inc. (BINP) Poised to Help Businesses Optimize the Customer Acquisition Experience Using AI
Via Investor Brand Network
Topics Artificial Intelligence
AINewsBreaks – AI Maverick Intel Inc. (BINP) Moves Beyond Lead Gen with Consultative Sales Platform
Via Investor Brand Network
Topics Artificial Intelligence
AI Maverick Intel Inc. (BINP) Transforms Customer Acquisition with AI-Driven Automation
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval
Via ACCESS Newswire
AINewsBreaks – Prospecting Reimagined: AI Maverick Intel Inc. (BINP) Automates the Human Touch
Via Investor Brand Network
Topics Artificial Intelligence
AI Maverick Intel Inc. (BINP) Unveils Revolutionary Prospecting Platform that Moves Beyond Simple Lead Generation
Via Investor Brand Network
Topics Artificial Intelligence
AI Maverick Intel Inc. (BINP): AI-Powered Prospecting Steps Into the Sales Rep’s Shoes
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – AI Maverick Intel, Inc. (OTCID: BINP) Launches Next-Generation AI Prospecting Platform for Transactional and Consultative Sales
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
AI Maverick Intel Provides Corporate Update
Via ACCESS Newswire
TechMediaBreaks – Why AI Maverick Intel Inc. (BINP) Is ‘One to Watch’
Via Investor Brand Network
Topics Artificial Intelligence
AI Maverick Intel Inc. (BINP): The AI Platform That Might Just Replace Your SDR Team
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – AI Maverick Intel, Inc. (OTCID: BINP) Engages IBN to Lead Corporate Communications Strategy
Via Investor Brand Network
Topics Artificial Intelligence
AI Maverick Intel Inc. (BINP) Is ‘One to Watch’
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
IBN Initiates Coverage of AI Maverick Intel Inc.
Via ACCESS Newswire
AINewsBreaks – AI Maverick Intel Inc. (OTC PINK: BINP) Launches Full-Scale AI Prospecting Engine for Automated Sales Engagement
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Launches Full-Scale AI Prospecting Engine for Automated Sales Engagement
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
AI Maverick Launches Enhanced Prospecting Platform to Deliver Human Like Outreach - No SDR Team Required
Via ACCESS Newswire
News headline image
AI Maverick Launches Enhanced Prospecting Platform to Deliver Human-Like Outreach—No SDR Team Required
From AI Maverick Intel, Inc.
Via GlobeNewswire
TechMediaBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Rebrands as AI Maverick Intel to Focus on AI-Driven Engagement
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
Via ACCESS Newswire
News headline image
Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
Via ACCESS Newswire
News headline image
Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements
Via ACCESS Newswire
News headline image
Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity
Via ACCESS Newswire
News headline image
Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm
Via ACCESS Newswire
News headline image
Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
Via ACCESSWIRE
News headline image
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
Via ACCESSWIRE
News headline image
Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.
Via ACCESSWIRE
News headline image
AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast
Via ACCESSWIRE
News headline image
The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time
Via ACCESSWIRE
< Previous 1 2 Next >